Pharmaceutical PreparationsCytochrome P-450 Enzyme SystemHexobarbitalMetabolic Detoxication, DrugAntipyrineCytochrome P-450 CYP3APharmacokineticsMicrosomes, LiverAryl Hydrocarbon HydroxylasesBiotransformationLiverLipid MetabolismEnergy MetabolismXenobioticsMetabolic Detoxication, Phase IMetabolic Detoxication, Phase IICytochrome P-450 CYP2D6UmbelliferonesHepatocytesPharmacogeneticsHydroxylationMixed Function OxygenasesOxidoreductases, N-DemethylatingReceptors, SteroidGlucuronosyltransferaseAminopyrineDrug InteractionsPhenobarbital7-Alkoxycoumarin O-DealkylaseAminopyrine N-DemethylaseHalf-LifeCoumarinsSteroid 16-alpha-HydroxylaseCytochrome P-450 CYP1A2KetoconazoleMetabolic Clearance RateEthylmorphine-N-DemethylaseDextromethorphanMetabolismNADPH-Ferrihemoprotein ReductaseCytochromes b5DealkylationNitrazepamEnzyme InductionChromatography, High Pressure LiquidAniline HydroxylaseMethaqualoneGlucoseDrug-Related Side Effects and Adverse ReactionsMidazolamOxidation-ReductionIsoenzymesKineticsReceptors, Cytoplasmic and NuclearAmobarbitalTolbutamideSteroid HydroxylasesDebrisoquinCytochrome P-450 CYP2E1CarboxylesteraseAcetaminophenMicrosomesMephenytoinSerial PublicationsPhenylbutazoneDrug Evaluation, PreclinicalSparteineOxygenasesSafety-Based Drug WithdrawalsChromatography, LiquidRNA, MessengerGlucuronidesMass SpectrometryRats, Sprague-DawleyGene Expression Regulation, EnzymologicPolymorphism, GeneticSubstrate SpecificityModels, BiologicalTime FactorsAminoethylphosphonic AcidCytochrome P-450 CYP1A1Biological TransportCarbon RadioisotopesPhenytoinQuantitative Structure-Activity RelationshipLiver, ArtificialSocieties, PharmaceuticalChlorzoxazoneP-GlycoproteinSpecies SpecificityDose-Response Relationship, DrugCells, CulturedHesperidinGlutathione TransferaseGenotypeGene Expression ProfilingProdrugsDrug-Induced Liver InjuryHep G2 CellsGlycolysis